NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/23/2025
Back to search
Official data from USPTO
QS-ORAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
09/23/2025
Trademark type
Word
Nice classes
5
Filing date
02/28/2025
Registration date
09/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2025
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/22/2023
First use in commerce
11/22/2023
Drawing code
4
Owner type
03
Owner location
Forestdale, MA
Examiner
TORPEY, KATHERINE ANN
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Q-VANT Biosciences, Inc.
Representatives
Rodney L. Skoglund Renner, Kenner, Greive, Bobak, Taylor & Weber
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Oral vaccine preparations; Adjuvants for use with vaccines; Adjuvants for medical purposes; Human vaccine preparations; Vaccine adjuvants; Vaccine preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Plant extractsother than essential oilsfor pharmaceutical purposes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of viral diseases
Publications
History of USPTO decisions and trademark events.
15 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/23/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/27/2025
IUAA
USE AMENDMENT ACCEPTED
08/27/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/22/2025
IUAF
USE AMENDMENT FILED
08/22/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/22/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2025
GNRT
NON-FINAL ACTION E-MAILED
08/04/2025
CNRT
NON-FINAL ACTION WRITTEN
08/04/2025
DOCK
ASSIGNED TO EXAMINER
08/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2025
NWAP
NEW APPLICATION ENTERED
02/28/2025
Continuous trademark protection
Get notified about every new filing that threatens QS-ORAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.